Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9998 |
MIND4-19
|
Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
MIND4-19 是一种具有抗肿瘤活性的 SIRT2 抑制剂。 | |||
T8452 |
Dantrolene
|
Others | Others |
Dantrolene 是一种肌肉松弛剂,是人红细胞谷胱甘肽还原酶的非竞争性抑制剂,其Ki 和IC50值分别为 111.6 μM 和 52.3 μM。它是兰尼碱受体拮抗剂及Ca2+信号稳定剂。它可用于研究恶性高热、亨廷顿病、肌肉痉挛和其他神经阻滞剂恶性综合征。 | |||
T6111 |
Selisistat
EX-527,司来司他,SEN0014196 |
Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
Selisistat (EX-527) 是一种去乙酰化酶 SIRT1 的抑制剂 (IC50=38 nM),具有有效性和特异性。Selisistat 可以用于神经系统疾病如亨廷顿舞蹈病的研究。 | |||
T22595 |
B2
Linazolamide intermediate B impurity 2,CPNQ,5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline,奥司他韦杂质B(2-叠氮杂合物) |
Others; Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair; Others |
B2 (Linazolamide intermediate B impurity 2) 促进亨廷顿病和帕金森病细胞模型中的包涵体形成。 | |||
T38605 |
NCT-504
|
Others | Others |
NCT-504, a selective allosteric inhibitor of PIP4Kγ, exhibits an IC50 value of 15.8 μM. It holds promise for the investigation of Huntington's disease. | |||
T9159 |
PBT-1033
PB 1033,PBT1033,PBT-2,PBT 2,PBT2 |
Others | Others |
PBT-1033 (PBT-2) 是一种潜在的神经保护剂,用于治疗阿尔茨海默病和亨廷顿病。 | |||
T23331 |
SC 51089
SC 51089 free base |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
SC 51089 是一种选择性的前列腺素受体 PGE2 拮抗剂,对前列腺素受体亚型具有选择性,具有抗伤害活性,可改善亨廷顿病 R6/1 小鼠模型中的运动缺陷并挽救记忆力下降。 | |||
T62839 |
Dalzanemdor
SAGE-718 |
NMDAR; iGluR | Membrane transporter/Ion channel; Neuroscience |
Dalzanemdor (SAGE-718) 是 NMDA 受体阳性变构调节剂,可用于研究亨廷顿舞蹈病、阿尔茨海默病和认知功能障碍。 | |||
T61859 |
MK-28
|
Antiviral; PERK | Apoptosis; Immunology/Inflammation |
MK-28 是一种具有选择性的 PERK 激动剂,可降低亨廷顿病模型的毒性并延长生存期。MK-28 对MK28胃癌细胞有显著的杀伤作用。 | |||
T2075 |
Pyrazolo[1,5-a]pyrimidine 4h
|
Others | Others |
Pyrazolo[1,5-a]pyrimidine 4h 是一种吗啉衍生物,是腺苷 A2A 受体的选择性拮抗剂。在帕金森病和亨廷顿舞蹈症的动物模型中,它已被证明具有神经保护作用。 | |||
T9340 |
1-phenyl-3,4-dihydroisochinoline
3,4-Dihydro-1-phenylisoquinoline,1-苯基-3,4-二氢异喹啉 |
Others | Others |
1-phenyl-3,4-dihydroisochinoline (3,4-Dihydro-1-phenylisoquinoline) 是神经递质多巴胺的结构类似物,与中枢神经系统中的多巴胺受体相互作用。它已被研究为治疗帕金森病、阿尔茨海默病和亨廷顿舞蹈症等神经疾病的潜在治疗剂。 | |||
T13133 |
Tetrabenazine Metabolite
(-)-β-Dihydrotetrabenazine,(-)-β-HTBZ |
Monoamine Transporter | Membrane transporter/Ion channel |
Tetrabenazine Metabolite ((-)-β-HTBZ) 是一种囊泡单胺转运蛋白 2 (VMAT2) 抑制剂,是 Tetrabenazine 的一种活性代谢物。Tetrabenazine Metabolite 对 VMAT2 具有高亲和力,其Ki 为13.4 nM。Tetrabenazine Metabolite 常常被用于研究与亨廷顿氏病和其他多动障碍相关的舞蹈病。 | |||
T40652 |
Meclizine
Meclozine |
Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Meclizine (Meclozine) (Meclozine)具有抗组胺作用,可可逆地抑制组胺与H1受体的相互作用。Meclizine 是哌嗪类H1拮抗剂的一个成员。Meclizine 是一种有效的抗运动病剂。Meclizine 可通过血脑屏障。Meclizine 是小鼠组成型雄烷受体(CAR)的激动剂配体,也是人CAR 的反向激动剂。Meclizine 可用于polyQ 毒性疾病的研究,如亨廷顿病。 | |||
T39480 |
Lexanersen
WVE-120102,Lexanersen |
||
Lexanersen (WVE-120102), an antisense oligonucleotide, is utilized in Huntington's disease research. | |||
T40843 |
1-(Anilinocarbonyl)proline
|
||
1-(Anilinocarbonyl)proline is a compound utilized for identifying dual-action probes within a cell model of Huntington's disease. | |||
T33895 |
PBT-1033 hydrochloride
PBT 1033,PBT2,PBT 2,PBT-2,PBT1033,PBT-1033 |
||
PBT-1033 hydrochloride is a potential neuroprotective agent for the treatment of Alzheimer's disease and Huntington's disease. | |||
T28363 | PF-02545920 | ||
PF-02545920, a PDE10 inhibitor, is used potentially for the treatment of Huntington's Disease. | |||
T69441 |
NSC66098
|
||
NSC66098 is a novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein. | |||
T71969 |
Remacemide
|
||
Remacemide is a low-affinity NMDA antagonist with sodium channel blocking properties. It has been studied for the treatment of acute ischemic stroke, epilepsy, Huntington's disease, and Parkinson's disease. | |||
T34662 |
SMER10
SMER-10,SMER 10 |
||
SMER10 is an enhancer of the clearance of mutant aggregate-prone proteins by autophagy in mammalian cell models of Huntington's and Parkinson's disease, independent of rapamycin. | |||
T79865 |
Votoplam
|
DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Votoplam作为一种基因剪接调节剂,其应用主要在于抑制亨廷顿病。 | |||
T38279 |
C2-8
C2-8 |
||
C2-8 is an inhibitor of polyglutamine (polyQ) aggregation (IC50s = 25 and 0.05 μM for recombinant HDQ51 and in PC12 cells, respectively). It also inhibits polyQ aggregation in organotypic hippocampal slice cultures isolated from R6/2 transgenic mice and reduces neurodegeneration in a dose-dependent manner in a Drosophila model of Huntington's disease. C2-8 (100 and 200 mg/kg) reduces huntingtin aggregate size, reduces neuronal atrophy, and improves motor performance in a rotarod test in the R6/2... | |||
T26683 |
AUTEN-67
Autophagy enhancer 67,MTMR14 inhibitor,AUTEN67 |
||
AUTEN-67 is a specific inhibitor of MTMR14 and autophagy enhancer with potent antiaging and neuroprotective effects. AUTEN-67 also delays the onset and decreases the severity of Huntington's disease. | |||
T7352L |
Pridopidine hydrochloride
ASP2314 HCl,Pridopidine HCl,FR310826,ASP-2314 hydrochloride |
||
Pridopidine Hydrochloride is a dopaminergic stabilizer that has been shown to improve a variety of neurological and psychiatric disorders, including Huntington's disease. Pridopidine Hydrochloride stabilizes psychomotor activity in a state-dependent way t | |||
T38146 |
Chloroguanabenz (acetate)
|
||
Chloroguanabenz is an antiprion agent and a derivative of the α2-adrenergic receptor agonist guanabenz . It inhibits prion formation in yeast and mammalian cell-based assays. Chloroguanabenz reduces the levels of both soluble and aggregated forms of the truncated Huntingtin derivative Htt48 in an HEK293T cellular model of Huntington's disease. | |||
T80813 | WAY-354574 | Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
WAY-354574为针对Sirtuin(脱乙酰酶)的活性化合物,适用于亨廷顿病(HD)研究。 | |||
T61497 |
Rho-Kinase-IN-2
|
||
Rho-Kinase-IN-2 (Compound 23) is an orally active and selective inhibitor of Rho Kinase (ROCK), which can penetrate the central nervous system (CNS). It exhibits a high affinity for ROCK2 with an inhibition constant (IC50) of 3 nM. This compound is of potential interest for further investigations in the field of Huntington's disease research [1]. | |||
T79038 | Tau protein aggregation-IN-1 | ||
Tau protein aggregation-IN-1(化合物 0c)是一种针对Tau protein聚集的抑制剂。该化合物主要应用于研究蛋白质折叠障碍类疾病,包括阿尔茨海默病、痴呆、帕金森病、亨廷顿舞蹈病及基于朊病毒引起的海绵状脑病。 | |||
T61991 |
HTT-D3
|
||
HTT-D3 是有效的,具有口服活性的亨廷顿蛋白 (HTT) 剪接调节剂。 HTT-D3 促进 HTT mRNA 降解和 HTT 水平降低。HTT-D3 减少 p-糖蛋白 (P-gp) 流出,在亨廷顿病中具有研究价值。 | |||
T73289 | mHTT-IN-1 | ||
mHTT-IN-1 (Example 1) 为针对突变亨廷顿蛋白 (mHTT) 的高效抑制剂,该蛋白具毒性,主导遗传性常染色体显性神经退行性疾病—亨廷顿氏病 (HD) 的发生。mHTT-IN-1 能有效降低 mHTT 水平,其 EC50 值为 0.46 nM。 | |||
T83947 |
HDAC4 CHDI Degrader 11
|
||
HDAC4 CHDI Degrader 11是一种高效且选择性的HDAC4降解剂(PROTAC),其在Jurkat E6-1细胞和Jurkat细胞中的DC50值分别为4 nM和6 nM。该化合物由类IIa HDAC抑制剂三氟甲基噁二唑通过连接体与Von Hippel-Lindau (VHL) 蛋白的配体连接而成。在亨廷顿病小鼠细胞模型中,HDAC4 CHDI Degrader 11能强效地降解HDAC4(DC50= 1nM)。在神经母细胞瘤细胞系中,可与P-糖蛋白抑制剂Elacridar联用以实现更有效的降解。 | |||
T74247 |
TPE-MI
|
||
TPE-MI(Tetraphenylethene maleimide)在与马来酰亚胺与硫醇反应前不具荧光性。在与游离的半胱氨酸硫醇标记时,其荧光被激活,后者多在球形蛋白质的核心,仅在展开时显露。TPE-MI适用于测量细胞中未折叠蛋白质的负荷,并能在亨廷顿病诱导的多能干细胞模型中监测蛋白质平衡失衡,以及在形成可见聚合体之前,监测转染突变亨廷顿外显子1的细胞的状况。此外,TPE-MI用于检测双氢青蒿素处理后疟疾寄生虫的蛋白质损伤。应暗处储存。 |